IL-23 and axial disease: do they come together?

por Mease, Philip, van den Bosch, Filip
Publicado 2021

Peripheral spondyloarthritis: a neglected entity—state of the art

por Carron, Philippe, De Craemer, Ann-Sophie, Van den Bosch, Filip
Publicado 2020

Tumor necrosis factor-α blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification?

por Van den Bosch, Filip, De Keyser, Filip, Mielants, Herman, Veys, Eric M
Publicado 2005

Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy

por Rudwaleit, Martin, Van den Bosch, Filip, Kron, Martina, Kary, Sonja, Kupper, Hartmut
Publicado 2010

Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis

por Mease, Philip, Sieper, Joachim, Van den Bosch, Filip, Rahman, Proton, Karunaratne, P Mahinda, Pangan, Aileen L
Publicado 2015

Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study

por Van den Bosch, Filip, Ostor, Andrew J. K., Wassenberg, Siegfried, Chen, Naijun, Wang, Chen, Garg, Vishvas, Kalabic, Jasmina
Publicado 2017

Erratum to: Impact of Participation in the Adalimumab (Humira) Patient Support Program on Rheumatoid Arthritis Treatment Course: Results from the PASSION Study

por Van den Bosch, Filip, Ostor, Andrew J. K., Wassenberg, Siegfried, Chen, Naijun, Wang, Chen, Garg, Vishvas, Kalabic, Jasmina
Publicado 2017

Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study

por Tahir, Hasan, Deodhar, Atul, Genovese, Mark, Takeuchi, Tsutomu, Aelion, Jacob, Van den Bosch, Filip, Haemmerle, Sibylle, Richards, Hanno B.
Publicado 2017

MRI of the axial skeleton in spondyloarthritis: the many faces of new bone formation

por Laloo, Frederiek, Herregods, Nele, Jaremko, Jacob L., Carron, Philippe, Elewaut, Dirk, Van den Bosch, Filip, Verstraete, Koenraad, Jans, Lennart
Publicado 2019

Scintigraphic detection of TNF-driven inflammation by radiolabelled certolizumab pegol in patients with rheumatoid arthritis and spondyloarthritis

por Carron, Philippe, Lambert, Bieke, Van Praet, Liesbet, De Vos, Filip, Varkas, Gaëlle, Jans, Lennart, Elewaut, Dirk, Van den Bosch, Filip
Publicado 2016

Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis

por Ramiro, Sofia, Landewé, Robert, van Tubergen, Astrid, Boonen, Annelies, Stolwijk, Carmen, Dougados, Maxime, van den Bosch, Filip, van der Heijde, Désirée
Publicado 2015

The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study

por Bakker, Pauline, Moltó, Anna, Etcheto, Adrien, Van den Bosch, Filip, Landewé, Robert, van Gaalen, Floris, Dougados, Maxime, van der Heijde, Désirée
Publicado 2017

Long-term efficacy and predictors of remission following adalimumab treatment in peripheral spondyloarthritis: 3-year results from ABILITY-2

por Van den Bosch, Filip, Mease, Philip J, Sieper, Joachim, Baeten, Dominique L, Xia, Yinglin, Chen, Su, Pangan, Aileen L, Song, In-Ho
Publicado 2018

Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study

por Webers, Casper, Ramiro, Sofia, Landewé, Robert, van der Heijde, Désirée, van den Bosch, Filip, Dougados, Maxime, van Tubergen, Astrid, Boonen, Annelies
Publicado 2018

Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of ax...

por Sepriano, Alexandre, Regel, Andrea, van der Heijde, Désirée, Braun, Jürgen, Baraliakos, Xenofon, Landewé, Robert, Van den Bosch, Filip, Falzon, Louise, Ramiro, Sofia
Publicado 2017

Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations...

por Regel, Andrea, Sepriano, Alexandre, Baraliakos, Xenofon, van der Heijde, Désirée, Braun, Jürgen, Landewé, Robert, Van den Bosch, Filip, Falzon, Louise, Ramiro, Sofia
Publicado 2017

Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study

por Baraliakos, Xenofon, Braun, Juergen, Deodhar, Atul, Poddubnyy, Denis, Kivitz, Alan, Tahir, Hasan, Van den Bosch, Filip, Delicha, Evie-Maria, Talloczy, Zsolt, Fierlinger, Anke
Publicado 2019

Extent of axial damage in psoriatic arthritis and spondyloarthritis: comparative data from the BEPAS and (Be-)GIANT multicentre cohorts

por de Hooge, Manouk, Ishchenko, Alla, De Craemer, Ann-Sophie, Steinfeld, Serge, Nzeusseu, Adrien, Elewaut, Dirk, Lories, Rik, de Vlam, Kurt, Van den Bosch, Filip
Publicado 2023

(99m)Tc-labelled S-HYNIC certolizumab pegol in rheumatoid arthritis and spondyloarthritis patients: a biodistribution and dosimetry study

por Lambert, Bieke, Carron, Philippe, D’Asseler, Yves, Bacher, Klaus, Van den Bosch, Filip, Elewaut, Dirk, Verbruggen, Gust, Beyaert, Rudi, Dumolyn, Caroline, De Vos, Filip
Publicado 2016

Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomise...

por Landewé, Robert BM, Gensler, Lianne S, Poddubnyy, Denis, Rahman, Proton, Hojnik, Maja, Li, Xiaoqi, Liu Leage, Soyi, Adams, David, Carlier, Hilde, Van den Bosch, Filip
Publicado 2021